These results demonstrate that AQP3 mediates chemoresistance to cDDP in gastric cancer cells, consistent with the association between AQP3 overexpression and poor prognosis in GC,12 despite the current lack of clinical evidence. Here, AQP3 is linked to gastric cancer.